Please login to the form below

Not currently logged in
Email:
Password:

Amryt Pharma appoints Jordi Casals as head of Europe

He joins the company from Aegerion Pharmaceuticals

Jordi CasalsAmryt Pharma, a company focused on treatments for rare and orphan diseases, has appointed Jordi Casals as the biopharma’s head of Europe.

Taking responsibility for leading and developing Amryt’s European operations, Casals’ new role will see him initially focus on the sales growth of the company’s commercial asset Lojuxta - a treatment for adult patients with Homozygous Familial Hypercholesterolaemia.

Dr Joe Wiley, chief executive officer of Amryt, said: “I am pleased to welcome Jordi to our senior management team as the company’s head of Europe.

“His significant commercial experience of European markets will help us to drive and further develop Amryt’s growth across this key region.”

Casal has over 20 years’ experience in the pharmaceutical and biotech industry and most recently worked for Aegerion Pharmaceuticals as a consultant, managing its commercial operations in the Iberia region.

Prior to this, he worked for eight years at Alexion Pharmaceuticals, latterly as vice president commercial operations, Western Europe.

9th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics